ELMELECH IDAN enters BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. with 14.84K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/30/2026ACC: 0001193125-26-197346
Officer· COO & Principal Financial Ofcr
Since Apr 2026
14.84K
Baseline shares
100% direct
14.84K
Direct ownership
1 position
310.29K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned14.84K
Total
14.84K direct14.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.84K | Direct |
| Total | 14.84K | 14.84K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
129.68K
Shares owned
N/A
Exercise price
4.17
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
7.77K
Shares owned
N/A
Exercise price
7.88
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
68.31K
Shares owned
N/A
Exercise price
10.19
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
104.54K
Shares owned
N/A
Exercise price
9.59
Expiration
—
Exercise window
—
Total
Underlying
310.29K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 4.17 | — | — | 129.68K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.88 | — | — | 7.77K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 10.19 | — | — | 68.31K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.59 | — | — | 104.54K | N/A |
| Total | 310.29K | 0.00 | ||||